Literature DB >> 2425585

Modulation of histamine release from rat peritoneal mast cells by non-cytotoxic concentrations of the detergents Cremophor El (oxethylated castor oil) and Triton X100. A possible explanation for unexpected adverse drug reactions?

M Ennis, W Lorenz, W Gerland.   

Abstract

Clinically relevant histamine release caused by drugs and/or their solvents is a well known phenomenon. The mechanisms whereby these reactions occur are largely unknown. It was thought that the solubilizing agents potentiate the histamine release elicited by the drugs. Therefore the ability of the two detergents, Cremophor El and Triton X100, to modulate histamine release from rat peritoneal mast cells was examined. Both detergents were used in concentrations that did not themselves induce histamine release. The addition of the detergents to incubation media containing compound 48/80 (0.1 microgram/ml) elevated the release considerably (48/80 alone = 16.2 +/- 2.1% (n = 3); plus Cremophor El (5%) = 41.1 +/- 3.3% (n = 4); plus Triton X100 (0.02 microliter/ml) = 39.7 +/- 3.9% (n = 3); plus Triton X100 (0.01 microliter/ml) = 33.4 +/- 5.0% (n = 3)). In contrast, histamine release induced by Concanavalin A or the calcium ionophore A 23187 was inhibited by both detergents. Thus low concentrations of detergents appear to have a dual role, with both potentiation and inhibition of histamine release being observed. Surgical patients receive many drugs, some soluble in aqueous solutions, others only with the aid of solubilizing agents. 'Hangover effects' due to different plasma half lives, may therefore cause a seemingly harmless drug to act as a histamine liberator. It is therefore important to examine the action of clinically used solvents on histamine liberation caused by therapeutic agents, in order to gain a further understanding of the reaction mechanisms of adverse reactions to drugs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425585     DOI: 10.1007/bf01988029

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  Histamine release after intravenous application of short-acting hypnotics. A comparison of etomidate, Althesin (CT1341) and propanidid.

Authors:  A Doenicke; W Lorenz; R Beigl; H Bezecny; G Uhlig; L Kalmar; B Praetorius; G Mann
Journal:  Br J Anaesth       Date:  1973-11       Impact factor: 9.166

2.  An improved method for the determination of histamine release in man: its application in studies with propanidid and thiopentone.

Authors:  W Lorenz; A Doenicke; R Meyer; H J Reimann; J Kusche; H Barth; H Geesing; M Hutzel; B Weissenbacher
Journal:  Eur J Pharmacol       Date:  1972-08       Impact factor: 4.432

3.  Role of intra- and extracellular calcium in histamine release from rat peritoneal mast cells.

Authors:  F L Pearce; M Ennis; A Truneh; J R White
Journal:  Agents Actions       Date:  1981-04

4.  Modulation of histamine release by fatty acids. A new in vitro model investigating adverse drug reactions in various species.

Authors:  M Ennis; W Lorenz
Journal:  Ann Fr Anesth Reanim       Date:  1985

5.  Florometric histamine determination in canine plasma under normal conditions, following application of exogenous histamine, and during histamine release by haemaccel.

Authors:  W Lorenz; H Barth; M Thermann; A Schmal; P Dormann; I Niemeyer
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1974-09

6.  Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines.

Authors:  G W Read; E F Kiefer
Journal:  J Pharmacol Exp Ther       Date:  1979-12       Impact factor: 4.030

7.  Plasma histamine levels in patients in the course of several standard operations: influence of anaesthesia, surgical trauma and blood transfusion.

Authors:  H D Röher; W Lorenz; H Lennartz; J Kusche; W Dietz; B Gerdes; J V Parkin
Journal:  Klin Wochenschr       Date:  1982-09-01
  7 in total
  3 in total

1.  Workgroup Report by the Joint Task Force Involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse Reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup-Allergic Reactions to Botulinum Antitoxin: A Systematic Review.

Authors:  Edith Schussler; Jeremy Sobel; Joy Hsu; Patricia Yu; Dana Meaney-Delman; Leslie C Grammer; Anna Nowak-Wegrzyn
Journal:  Clin Infect Dis       Date:  2017-12-27       Impact factor: 9.079

2.  Histamine release induced by opioid analgesics: a comparative study using porcine mast cells.

Authors:  M Ennis; C Schneider; E Nehring; W Lorenz
Journal:  Agents Actions       Date:  1991-05

3.  Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacrolimus (FK 506) in rats.

Authors:  M J Lee; R M Straubinger; W J Jusko
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.